Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. (WHTCF) is a digital healthcare company that frequently issues detailed updates on its clinic operations, technology platform, and financial performance. News about WELL often highlights developments across its Canadian Patient Services segment, its U.S. specialty markets, and its majority‑owned SaaS subsidiary, WELLSTAR Technologies Corp.
Investors following WHTCF news can expect regular coverage of quarterly results, including trends in revenue, adjusted EBITDA, and patient visits across the company’s clinic network. WELL also reports on clinic acquisitions, expansion of its Canadian clinics platform, and changes to its senior secured credit facility that support its acquisition pipeline and growth plans.
Another major theme in WELL’s news flow is clinic digitization and AI‑enabled tools. The company provides updates on the progress of digital transformation in its primary care clinics, including adoption of online booking, self‑check‑in, digital reminders, and digital consents. It also announces new AI‑powered products and deployments across its network, such as AI ambient scribe solutions and decision support tools.
WELLSTAR‑related announcements are an important component of WELL’s news. These items cover WELLSTAR’s recurring revenue growth, new contracts for digital health platforms, acquisitions of SaaS and billing assets, and equity financings intended to fund future growth and potential spin‑out plans. Together, these updates offer insight into WELL’s combined strategy of operating a large outpatient clinic network while scaling a healthcare technology platform.
For readers tracking WHTCF, this news page aggregates company press releases and market‑moving updates in one place, making it easier to review WELL’s operational milestones, technology initiatives, and capital markets activity over time.
WELL Health Technologies (OTCQX:WHTCF) and its subsidiary WELLSTAR Technologies announced their participation in the upcoming 2025 Cantech Investment Conference on October 9, 2025, in Toronto. WELL's CEO Hamed Shahbazi and WELLSTAR's CEO Amir Javidan will present at 1:30 PM EST and 4:00 PM EST respectively.
The presentations will focus on WELL's capital-efficient growth strategy and WELLSTAR's technological capabilities. As the largest provider of outpatient services in Canada, WELL will highlight its implementation of WELLSTAR and HEALWELL AI technologies across its clinic network to enhance provider efficiency and patient care.
WELL Health Technologies (OTCQX:WHTCF) reported exceptional Q2-2025 results with record-breaking performance across key metrics. The company achieved record quarterly revenue of $356.7M, up 57% year-over-year, and Adjusted EBITDA of $49.7M, surging 231% compared to Q2-2024.
Key highlights include Adjusted Net Income of $25.8M ($0.10/share), up 532% YoY, and a milestone achievement of over 1 million patient visits in Canada during the quarter. The company's Canadian Patient Services revenue grew 49% to $114.5M, with 17.8% organic growth.
WELL upgraded its 2025 guidance, expecting revenue between $1.40B-$1.45B and Adjusted EBITDA in the upper half of $190M-$210M. The company also completed strategic acquisitions and expanded its credit facility to $200M, positioning for continued growth.
WELL Health Technologies (OTCQX:WHTCF), a digital healthcare company, has scheduled its Second Quarter 2025 financial results announcement for August 14, 2025, before market opening.
The company will host a conference call and webcast on the same day at 1:00 PM ET to discuss the results. CEO Hamed Shahbazi and CFO Eva Fong will lead the discussion. Participants can join via phone using North American toll-free number 1-800-717-1738 or international number 289-514-5100.
WELL Health Technologies (TSX: WELL, OTC: WHTCF) has provided an updated corporate outlook for its Canadian Clinics Business, announcing significant growth and improved financial guidance. The company has raised its 2025 guidance for Canadian Patient Services to over $450 million in revenue (41% YoY increase) and over $60 million in Adjusted EBITDA (47% YoY increase).
Key developments include: (1) Two strategic clinic acquisitions in British Columbia completed on July 1, 2025, expected to add $12 million in annual revenue and $3 million in Adjusted EBITDA; (2) An expanded credit facility led by RBC, increased to $200 million and extended to 2027; (3) A robust M&A pipeline of 124 clinics representing $370 million in potential revenue; and (4) Implementation of a multi-million-dollar cost optimization initiative across Canadian operations.
WELL Health Technologies (OTCQX:WHTCF), a digital healthcare company, has announced the voting results from its annual general meeting held on June 30, 2025. All nominated directors were successfully elected, with 67,105,724 common shares (representing 26.52% of outstanding shares) voted by proxy.
The election results showed varying levels of support for the directors, with Sybil E Jen Lau receiving the highest approval at 97.61%, while CEO and Chairman Hamed Shahbazi received 73.15% support. Other directors, including John Kim (94.42%), Thomas Liston (87.80%), Tara McCarville (87.51%), and Kenneth Cawkell (82.45%), were also elected.
WELL Health Technologies (OTCQX:WHTCF) has announced a significant expansion in primary care capacity, opening 45,000+ new patient slots across Ontario (13,000+), Alberta (~21,000), and Manitoba (11,000+). This expansion is driven by successful physician recruitment, particularly internationally trained doctors, and digital transformation initiatives.
The company is leveraging WELLSTAR Technologies to power its clinics with advanced digital workflows, including the Nexus AI™ ambient scribe and OceanMD's patient engagement platform. Through its subsidiary Physicians For You, WELL has placed 25 new internationally trained physicians in the last 6 months and plans to onboard 20 more in 2025.
WELL Health Technologies (WHTCF) has established an automatic share purchase plan (ASPP) to facilitate its previously announced normal course issuer bid (NCIB). The company received TSX approval to repurchase up to 6,326,417 common shares, representing approximately 2.5% of its 253,056,708 outstanding shares, between May 20, 2025, and May 19, 2026.
The ASPP allows WELL's broker to purchase shares during periods when the company would typically be restricted from trading due to insider trading rules and internal blackout periods. Purchases will be made based on pre-set parameters established by WELL when it has no undisclosed material information.
["Company authorized to repurchase 6.3M shares (2.5% of outstanding shares)", "ASPP enables consistent share repurchases even during blackout periods", "Share buyback demonstrates management's confidence in company value"]